Crossmark

Elucidating the mechanism of action of domatinostat (4SC-202) in cutaneous T cell lymphoma cells

Crossref DOI link: https://doi.org/10.1186/s13045-019-0719-4

Published Online: 2019-03-18

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wobser, Marion

Weber, Alexandra

Glunz, Amelie

Tauch, Saskia

Seitz, Kristina

Butelmann, Tobias

Hesbacher, Sonja

Goebeler, Matthias

Bartz, René

Kohlhof, Hella

Schrama, David

Houben, Roland https://orcid.org/0000-0003-4538-2324
Funding

Funding for this research was provided by:

Deutsche Forschungsgemeinschaft (funding programme Open Access Publishing)

LEO Foundation Award (Gold Award 2012)

University of Würzburg (funding programme Open Access Publishing)
License Information

Text and Data Mining valid from 2019-03-18
More Information

Article History

Received: 26 October 2018

Accepted: 7 March 2019

First Online: 18 March 2019

Authors’ information

: Not applicable.

: Not applicable.

: Not applicable.

: The study was performed at the dermatology department in Würzburg. The 4SC AG, which develops small molecule inhibitors for cancer therapy, provided reagents and covered costs for selected consumables for this study. Rene Bartz is and Hella Kohlhof has been a former employee of 4SC AG. The other authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.